ACHE and Alzheimer disease: The tested extract and isolated compounds exhibited moderate-togood inhibitions for both AChE and BChE, indicating their pharmacological potential in terms of the palliation of the symptoms and treatment of AD, as well as possibly reducing the progression of the disease by interfering with the cholinergic system.